Loading asset research
KALA BIO Inc. Common Stock
KALANasdaq · USD · StocksQuote as of · Exchange session not verified$0.572
+1.60%
Today
KALA
Loading 1D prices…
Market cap
$11.1M
Volume
111.2K
52w high
$1,030.0052w low
$0.49Company profile
KALA BIO Inc. Common Stock
KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic AI research platform for private enterprise AI deployment. Its platform intends to utilize the KPI-012 clinical development dataset as a proof-of-concept validation environment, as well as the mesenchymal stem cell secretome (MSC-S) and persistent corneal epithelial defects (PCED) research for agentic workflows on trial data. The company serves biotechnology and pharmaceutical companies. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Arlington, MA, United States
Employees
6
Fiscal year end
1231
CIK
1479419
Session & valuation
Open$0.592
Previous close$0.563
Day high$0.60
Day low$0.572
30-day avg. volume514.8K
Outstanding shares19.3M
Diluted EPS-$3.31
Latest annual period
P/E (trailing)-0.17
P/E (forward)-0.09
Price / book1.22
Beta-2.29
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| MTVAMetaVia Inc. Common Stock | $10.9M | $0.00 | — | -$7.35 | -5.14% | Buy |
| AZTRAzitra Inc Common Stock | $10.8M | $0.00 | — | -$2.25 | -1.11% | Buy |
| LNAILunai Bioworks Inc. Common Stock | $10.8M | $20.9K | -7409.88% | -$0.07 | -2.26% | Unrated |
| TOVXTheriva Biologics Inc. Common Stock | $11.4M | $0.00 | — | -$2.08 | +4.17% | Buy |
| FBLGFibroBiologics Inc. Common Stock | $10.7M | $0.00 | — | -$0.42 | -6.94% | Buy |